T Lange, T Bumm, S Otto, HK Al-Ali, I Kovacs, D Krug, T Kohler, R Krahl, D Niederwieser, MW Deininger. Quantitative reverse transcription polymerase chain reaction should not replace conventional cytogenetics for monitoring patients with chronic myeloid leukemia during early phase of imatinib therapy. Haematologica 2004;89(1):49-57; https://doi.org/10.3324/%x.